About Neurogenic differentiation factor 6
Neurogenic differentiation factor 6 (NEUROD6) is a protein
from Homo sapiens identified by UniProt accession
Q96NK8, 337 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | Neurogenic differentiation factor 6 |
| UniProt accession | Q96NK8 |
| Gene | NEUROD6 |
| Organism | Homo sapiens |
| Length | 337 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- age at first sexual intercourse measurement · score 0.38
- self reported educational attainment · score 0.27
- emotional symptom measurement · score 0.27
- attention deficit hyperactivity disorder · score 0.26
- antisocial behaviour measurement · score 0.26
- substance abuse · score 0.26
- brain volume measurement · score 0.25
- neuroimaging measurement · score 0.25
- hippocampal tail volume · score 0.25
- smoking status measurement · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96NK8-F1 | alphafold | PREDICTED | 62.10 | — |
Amino-acid sequence (337 residues)
MLTLPFDESV VMPESQMCRK FSRECEDQKQ IKKPESFSKQ IVLRGKSIKR APGEETEKEE EEEDREEEDE NGLPRRRGLR KKKTTKLRLE RVKFRRQEAN ARERNRMHGL NDALDNLRKV VPCYSKTQKL SKIETLRLAK NYIWALSEIL RIGKRPDLLT FVQNLCKGLS QPTTNLVAGC LQLNARSFLM GQGGEAAHHT RSPYSTFYPP YHSPELTTPP GHGTLDNSKS MKPYNYCSAY ESFYESTSPE CASPQFEGPL SPPPINYNGI FSLKQEETLD YGKNYNYGMH YCAVPPRGPL GQGAMFRLPT DSHFPYDLHL RSQSLTMQDE LNAVFHN
Explore Neurogenic differentiation factor 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets